BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Trapé J, Filella X, Alsina-Donadeu M, Juan-Pereira L, Bosch-Ferrer Á, Rigo-Bonnin R. Increased plasma concentrations of tumour markers in the absence of neoplasia. Clin Chem Lab Med. 2011;49:1605-1620. [PMID: 21892908 DOI: 10.1515/CCLM.2011.694] [Cited by in Crossref: 45] [Cited by in F6Publishing: 9] [Article Influence: 4.1] [Reference Citation Analysis]
Number Citing Articles
1 Trapé J, Sant F, Montesinos J, Arnau A, Sala M, Figols C, Franquesa J, Esteve-Valverde E, Pérez R, Aligué J, Catot S, Casado E, Domenech M, Trapé-Ubeda J, Bergós C, Vida F, Sort P, Bonet M, Ruiz D, González-Fernández C, Ordeig J, Molina R. Comparative Assessment of Two Strategies for Interpreting Tumor Markers in Ascitic Effusions. In Vivo 2020;34:715-22. [PMID: 32111775 DOI: 10.21873/invivo.11829] [Reference Citation Analysis]
2 Mikkelsen G, Åsberg A, Hultström ME, Aasarød K, Hov GG. Reference limits for chromogranin A, CYFRA 21-1, CA 125, CA 19-9 and carcinoembryonic antigen in patients with chronic kidney disease. Int J Biol Markers 2017;32:e461-6. [PMID: 28561881 DOI: 10.5301/ijbm.5000278] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
3 Chen J, Tao F, Zhang B, Chen Q, Qiu Y, Luo Q, Gen Y, Meng J, Zhang J, Lu H. Elevated Squamous Cell Carcinoma Antigen, Cytokeratin 19 Fragment, and Carcinoembryonic Antigen Levels in Diabetic Nephropathy. Int J Endocrinol 2017;2017:5304391. [PMID: 28744310 DOI: 10.1155/2017/5304391] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
4 Orosz E, Ember I, Gombos K, Tóth L, Tarpay Á, Pap Á, Ottó S. Alternatives for the intensive follow-up after curative resection of colorectal cancer. Potential novel biomarkers for the recommendations. Pathol Oncol Res 2013;19:619-29. [PMID: 23868031 DOI: 10.1007/s12253-013-9672-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
5 Mirabelli P, Incoronato M. Usefulness of traditional serum biomarkers for management of breast cancer patients. Biomed Res Int 2013;2013:685641. [PMID: 24350285 DOI: 10.1155/2013/685641] [Cited by in Crossref: 27] [Cited by in F6Publishing: 33] [Article Influence: 3.0] [Reference Citation Analysis]
6 Bevan J, Richardson M. Diminution of falsely elevated tumour markers following immunosuppression for systemic lupus erythematosus with neurological involvement. BMJ Case Rep 2016;2016:bcr2016214549. [PMID: 27048397 DOI: 10.1136/bcr-2016-214549] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
7 Ayala de la Peña F, Ortiz-Muñoz B, Quintanar-Verdúguez T, Santotoribio JD, de la Cruz S, Trapé-Pujol J, Galve-Calvo E, Augé-Fradera JM, García-Gómez J, González-Hernández Á. Consensus of the Spanish society of laboratory medicine and the Spanish society of medical oncology on the methodology and criteria for evaluation of circulating tumour markers in breast cancer. Clin Transl Oncol 2021;23:1272-80. [PMID: 33550504 DOI: 10.1007/s12094-020-02529-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Vizin T, Kos J. Gamma-enolase: a well-known tumour marker, with a less-known role in cancer. Radiol Oncol 2015;49:217-26. [PMID: 26401126 DOI: 10.1515/raon-2015-0035] [Cited by in Crossref: 28] [Cited by in F6Publishing: 32] [Article Influence: 4.0] [Reference Citation Analysis]
9 Zhao HG, Jiao Y, Zhang ZC. Reference range determination for gastrointestinal tumor markers in patients on maintenance dialysis. Shijie Huaren Xiaohua Zazhi 2016; 24(15): 2429-2433 [DOI: 10.11569/wcjd.v24.i15.2429] [Reference Citation Analysis]
10 Trapé J, Sant F, Franquesa J, Montesinos J, Arnau A, Sala M, Bernadich O, Martín E, Perich D, Pérez C, Lopez J, Ros S, Esteve E, Pérez R, Aligué J, Gurt G, Catot S, Domenech M, Bosch J, Badal JM, Bonet M, Molina R, Ordeig J. Evaluation of two strategies for the interpretation of tumour markers in pleural effusions. Respir Res 2017;18:103. [PMID: 28545517 DOI: 10.1186/s12931-017-0582-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]